Stay updated with breaking news from Bio Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report issued on Wednesday morning. The brokerage issued a sell rating on the stock. Bio-Path Stock Up 1.5 % BPTH stock opened at $0.41 on Wednesday. The business has a fifty day moving average of $0.68 and a two-hundred day moving average […]
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note released on Tuesday morning. The brokerage issued a sell rating on the stock. Bio-Path Stock Up 3.3 % Bio-Path stock opened at $0.40 on Tuesday. The stock has a market cap of $4.53 million, a P/E ratio of -0.18 and […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the recipient of a significant decrease in short interest during the month of August. As of August 15th, there was short interest totalling 218,300 shares, a decrease of 46.7% from the July 31st total of 409,300 shares. Based on an average daily trading volume, of 335,100 […]
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report published on Sunday morning. The firm issued a sell rating on the stock. Bio-Path Trading Up 9.1 % NASDAQ BPTH opened at $0.40 on Friday. The company’s 50-day moving average price is $1.13 and its 200-day moving average price is $1.44. […]
Bio-Path (NASDAQ:BPTH – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.53) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.52) by ($0.01), MarketWatch Earnings reports. During the same quarter last year, the company posted ($0.42) earnings per share. Bio-Path Stock Performance NASDAQ:BPTH traded down $0.01 […]